MannKind Corp. (MNKD)
3.95
-0.11
(-2.71%)
USD |
NASDAQ |
Aug 28, 16:00
3.955
0.00 (0.00%)
After-Hours: 20:00
MannKind Free Cash Flow : -18.30M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.30M |
| March 31, 2026 | 13.07M |
| December 31, 2025 | 13.69M |
| September 30, 2025 | 42.74M |
| June 30, 2025 | 28.22M |
| March 31, 2025 | 21.32M |
| December 31, 2024 | 32.42M |
| September 30, 2024 | 28.54M |
| June 30, 2024 | 17.96M |
| March 31, 2024 | 2.885M |
| December 31, 2023 | -8.536M |
| September 30, 2023 | -31.78M |
| June 30, 2023 | -57.38M |
| March 31, 2023 | -72.21M |
| December 31, 2022 | -88.29M |
| September 30, 2022 | -98.33M |
| June 30, 2022 | -89.42M |
| March 31, 2022 | -82.77M |
| December 31, 2021 | -73.18M |
| September 30, 2021 | -55.90M |
| June 30, 2021 | -49.93M |
| March 31, 2021 | -31.27M |
| December 31, 2020 | -28.93M |
| September 30, 2020 | -33.88M |
| June 30, 2020 | -73.43M |
| Date | Value |
|---|---|
| March 31, 2020 | -90.55M |
| December 31, 2019 | -91.05M |
| September 30, 2019 | -61.20M |
| June 30, 2019 | -22.10M |
| March 31, 2019 | -28.30M |
| December 31, 2018 | -38.08M |
| September 30, 2018 | -92.70M |
| June 30, 2018 | -102.05M |
| March 31, 2018 | -94.94M |
| December 31, 2017 | -64.78M |
| September 30, 2017 | -47.55M |
| June 30, 2017 | -47.35M |
| March 31, 2017 | -38.82M |
| December 31, 2016 | -79.23M |
| September 30, 2016 | -90.18M |
| June 30, 2016 | -88.23M |
| March 31, 2016 | -99.06M |
| December 31, 2015 | -68.34M |
| September 30, 2015 | -85.36M |
| June 30, 2015 | 26.54M |
| March 31, 2015 | 17.20M |
| December 31, 2014 | -20.01M |
| September 30, 2014 | -19.52M |
| June 30, 2014 | -143.43M |
| March 31, 2014 | -141.63M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| United Therapeutics Corp. | 1.084B |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Gilead Sciences, Inc. | 12.94B |
| Vertex Pharmaceuticals, Inc. | 3.796B |
| Ocugen, Inc. | -61.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.63M |
| Cash from Investing (Quarterly) | 17.91M |
| Cash from Financing (Quarterly) | 0.819M |
| Free Cash Flow Per Share (Quarterly) | -0.0767 |
| Free Cash Flow to Equity (Quarterly) | -23.39M |
| Free Cash Flow to Firm (Quarterly) | -8.977M |
| Free Cash Flow Yield | -1.50% |